Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NVP-DPP728 dihydrochloride is a highly potent, selective, and orally active inhibitor of dipeptidyl peptidase IV (DPP-IV), with a binding affinity (K i ) of 11 nM. This compound proves useful for investigating diabetes mellitus in research studies.
产品描述 | NVP-DPP728 dihydrochloride is a highly potent, selective, and orally active inhibitor of dipeptidyl peptidase IV (DPP-IV), with a binding affinity (K i ) of 11 nM. This compound proves useful for investigating diabetes mellitus in research studies. |
靶点活性 | DPP-IV:11 nM (Ki) |
体外活性 | NVPDPP728 inhibits human and rat plasma DPP-IV (IC 50 s: 5-10 nM) with >15 000-fold selectivity relative to DPP-II and a range of proline-cleaving proteases[1]. |
体内活性 | NVP-DPP728 (3.72 mg/kg; p.o.) inhibits DPP-IV and improves insulin secretion and glucose tolerance, probably through augmentation of the effects of endogenous GLP-1[2]. Animal Model: Obese (fa/fa) and lean (FA/?) Zucker rats[2]Dosage: 3.72 mg/kg Administration: Oral administration Result: Led to inhibition of plasma DPP-IV activity. |
别名 | NVP-DPP728 dihydrochloride |
分子量 | 371.27 |
分子式 | C15H20Cl2N6O |
CAS No. | 207556-62-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
NVP-DPP728 dihydrochloride 207556-62-5 NVP DPP728 dihydrochloride NVP-DPP 728 NVP-DPP-728 dihydrochloride NVP-DPP-728 NVP-DPP-728 Dihydrochloride NVP-DPP 728 Dihydrochloride NVP-DPP728 Dihydrochloride NVP-DPP728 NVPDPP728 dihydrochloride Inhibitor inhibitor inhibit